Business
Teva Stock Soars 19% as Game-Changing IBD Drug Duvakitug Crushes Trial Expectations - Yahoo Finance
Teva up 19%, Sanofi 4% after duvakitug's trial success stuns investors. and for good reason
By: Yahoo Entertainment
- Dec 18 2024
- 0
- 0 Views

Easy Branches allows you to share your guest post within our network in any countries of the world to reach Global customers start sharing your stories today!
Easy Branches
34/17 Moo 3 Chao fah west Road, Phuket, Thailand, PhuketCall: 076 367 766
info@easybranches.comTeva up 19%, Sanofi 4% after duvakitug's trial success stuns investors. and for good reason